RSS

Blog

Hong Kong Investment Consortium begins investing in Merion, Inc.
On November 28, 2019 (Thursday), Hong Kong TBS Capital Management Ltd. Invested 2 million US dollars ( see SEC website announcement).
Chairman of a HK consortium remits to pre-order Remage Power-NMN products
On November 4, 2019, the chairman from a HK consortium remitted to pre-order ReMage Power-NMN products. In the current overrun NMN products marketing, it’s hard to distinguish whether it’s authentic or fake. But Merion product won the top spot in the same products, which got the favor of the rich people, consortium chairmen and beauty ladies. Thank you for your trust and support!
ReMage Power-NMN obtains US FDA filed Functional Food Export Certificate
On October 23, 2019, ReMage Power was approved by US FDA as a functional food, which can promote energy metabolism, cell health, anti-aging and promote NAD+.
Merion joins in VIIVA breakfast marketing team
On Oct 8, 2019, Merion, Inc joined the cooperation of VIIVA’s marketing force. The top executives of VIIVA are all successful entrepreneurs with strong economic strength, strong relationships and legal operations between China and United States. With our joining, we will develop a market for Merion with an additional window to obtain economic benefits.
Improving government projects cooperation and creating California’s “welfare” <br/>-- California Business counselling seminar of enterprise bureau
On May 20, 2019, 11 am, Ms. FIONA MA, State Treasure of California, led the leaders of the governor's business and economic development office and the head of California enterprise bureau to hold the " California Business counseling seminar of enterprise bureau "
2019 New Year Message 2019, A era of investment of big health industry
Health is the eternal topic of human beings, and it is an important indicator of society progress. The big health industry is becoming a global hotspot. After the “mechanization era” from steam engines and later the “electrical era”, “computer age “and “information network era”, now it’s the time for “health care era”.
The notice regarding the company information management regulation

According to the Insider Trading and Securities Fraud Enforcement Act passed by US Congress in 1988, the US Securities Regulatory Commission and the Department of Justice will impose civil penalties, fines and criminal penalties for any disclosure and use of company insider information to trade stocks. Our company is a public company registered with the US Securities and Exchange Commission and traded on OTC. The company stipulates that any company internal personnel, including directors, senior management and employees and other personnel involved in the company’s major insider information, should not disclose insider information of the company, otherwise it will have significant adverse consequences for the company, management and individuals, which is including collecting illegal income, a huge fine, not allowed to serve as a director and executive of any public company, the company was deregistered, delisted, and even the main responsible personnel were under criminal detention. In view of the significant consequences of violating insider trading regulations, the company stipulates that directors, offices and employees must not discuss any insider information with investors and shareholders. If investors and shareholders want to know the company’s current development, please visit SEC website www.sec.gov to find out the company’s situation. If you have any questions, please send an email to info@merionus.com, the company will review the relevant questions and give a reply based on the regulations.



From today, we will cancel the direct communication and WeChat contact between the customers who own the shares and the Chairman and company executives.



Hereby notice,







MERION, INC.
12/03/2018

News Release
On Nov. 14, 2018, the company file the third-quarter Form 10-Q on time. We are on the right track now. We will continue develop the market, increase the sales, and promote our high-tech small molecular+ carrier healthcare products to Southeast Asia market, and be well-known by most of the people.